clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Personalized Medicine
News & Features
News & Features
New Guidelines Released for Genetic Testing Post-PCI
News & Features
IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
News & Features
New Guidelines Released for Genetic Testing Post-PCI
News & Features
IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System
Molecular Dx
Gut Microbiome Changes Can Help Diagnose Fibromyalgia
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 5
Multimedia
All
Webinars
eBooks
Webinars
In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology
eBooks
Rethinking Rx-Dx Codevelopment
Webinars
Liquid Biopsy and ddPCR: A Match with Quality in Mind
Multimedia
Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Informatics
Bioinformatics
Bioinformatics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
June 20, 2019
Bioinformatics
Single Genetic Variant Associated with Cannabis Abuse
June 19, 2019
Bioinformatics
Tempus Attracts $200M in Series F Financing, Bringing Total Raised to...
May 31, 2019
Bioinformatics
EMBL-EBI Launches Free Genetic Disease Diagnostic Software
May 30, 2019
Bioinformatics
AI Finds Mutations in “Junk” DNA that Cause Autism
May 28, 2019
Bioinformatics
Clinical Trials Data Partnership Joins Verily with Pharma Giants
May 21, 2019
Bioinformatics
Panel Identifies Hurdles to Wider AI Use in Diagnostic, Rx Development
May 15, 2019
Bioinformatics
Congenica Raises Additional £13.25 in Series B Financing Round
April 30, 2019
Bioinformatics
Rady Researchers Use AI ‘Pipeline’ for Rapid Diagnosis of Rare Genetic...
April 25, 2019
Bioinformatics
Genomenon, Parabricks Offer Products Via Google Cloud Platform
April 16, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
